Wondering if Recursion Pharmaceuticals at around US$4.67 a share is priced for its potential or still misunderstood by the ...

If you have ever wondered whether Microsoft is still a buy at today’s levels, you are not alone. This article is designed to ...

Picture a budget meeting at a city agency or a corporate boardroom. A generative AI system drafts a cash-flow projection, summarizes a long policy memo, and suggests a pricing tweak or benefits change ...

As we steam ahead into 2026, two Nasdaq-100 stocks make for no-brainer buys, while another highflier is worth avoiding.

Navan is a relatively new IPO that is successfully disrupting the travel booking and management space. Learn more about NAVN ...

Global equity markets are up, but Q4 earnings season has begun, and the time of reckoning is here. Companies will either show ...

Discover how structural simplification and AI demand are reshaping Applied Digital Corporation valuations. Click for more on ...

Investors are glum about tariffs taking a bite out of Delta's guidance, sending shares down 3% as the carrier capped a banner ...

GE Vernova Inc. (NYSE:GEV) is one of the best performing S&P 500 stocks in 2025. On December 18, Baird raised the firm’s price target on GE Vernova to $816 from $706 and maintained an Outperform ...

The latest announcement is out from Global Mofy Metaverse Ltd. ( (GMM) ).

Hyundai plans to set up a manufacturing system to build thousands of robots by 2028, leaning on its majority stake in Boston ...

AI, machine learning, and algorithm-driven analytics are changing the face of foreign exchange (FX) trading and investment.